Neudle.com: multiple sclerosis primary progressive

Differential
(Click to cross reference)

abducens nerve paralysis

abscess, intracerebral

acquired immunodeficiency syndrome

acquired immunodeficiency syndrome dementia complex

acute disseminated encephalomyelitis

acute necrotizing encephalitis

adenylate kinase 5 autoantibodies

adverse drug reaction

affect, flat

Alexanders disease

Alexanders disease, adult onset

amphiphysin antibodies

amyloid angiopathy, cerebral

amyotrophic lateral sclerosis

amyotrophic lateral sclerosis, differential diagnosis

amyotrophic lateral sclerosis, misdiagnosis

amyotrophic lateral sclerosis, work up

aneurysm

aneurysm, cavernous sinus

aneurysm, internal carotid artery

angiitis

angiitis, granulomatous of CNS

angiitis, isolated of CNS

anti Hu antibody

antibiotics

antihistamines

arterial dissection, aorta

arteriovenous malformation

arteriovenous malformation, cerebral

autoimmune cerebellar ataxia

autoimmune disease

autonomic dysfunction

Barkhof MR criteria for MS

behavioral disorder

Behcet's syndrome

bone marrow biopsy

bone marrow suppression

brain biopsy

brainstem, lesion of

brucellosis, nervous system involvement with

Brudzinski's sign

carbon monoxide poisoning

CAT scan, emission, abnormal

CAT scan, serial

cavernous sinus, syndrome

central nervous system, infection of

central pontine myelinolysis

cerebellar atrophy, secondary

cerebellar degeneration

cerebellar lesion

cerebellar pontine angle tumor

cerebral autosomal dominate arteriopathy with subcortical infarction and leukoencephalopathy

cerebral cortex

cerebral cortical atrophy

cerebral infarction

cerebral peduncle

cerebral venous thrombosis

cerebrospinal fluid

cerebrospinal fluid, abnormal

cerebrospinal fluid, elevated protein of

cerebrospinal fluid, oligoclonal IgG in

cerebrovascular accident

cerebrovascular disease

cervical rib

cervical spine

cervical spondylosis

cervical spondylosis, differential diagnosis of

cervical spondylosis, misdiagnosis

chemotherapy, CNS treatment and complications with

Clinical Pathologic Conference(C.P.C.)

clinicoradiologic dissociation

collagen vascular disease

collapsin response mediator protein 5 IgG

complications

concentric sclerosis

confusion

contactin associated protein like 2 antibodies

controversies in neurology

cop 1

corpus callosum

corpus callosum, infarction of

corpus callosum, lesion of

corpus callosum, neoplasm of

cortical blindness

cost effectiveness

cranial neuropathy

cranial neuropathy, multiple

crying, pathologic

cryptococcal meningitis

cyclophosphamide

cyclosporine

cytomegalovirus infection

degenerative diseases of CNS

delirium

dementia

dementia, rapidly progressive

dementia, screening for

demyelinating disease

dermatomyositis

diabetes mellitus

diarrhea

differential diagnosis

diffuse axonal injury

disability rating scale, neurological

disability, neurological

disease modifying agents

drug abuse

drug induced neurologic disorders

electroencephalogram, abnormalities of

electromyogram

emotional lability

encephalitis

encephalitis, autoimmune

encephalitis, brainstem

encephalitis, human immunodeficiency virus type 1

encephalitis, paraneoplastic

encephalitis, viral

encephalomyelitis

encephalopathy

encephalopathy, Hashimoto's

encephalopathy, metabolic

epidemiology of neurology

facial weakness, bilateral

gammaglobulin therapy, intravenous

ganglionitis

genu of corpus callosum

glioblastoma multiforme(astrocytoma Gr.III)

glioma

gliomatosis cerebri

glutamic acid decarboxylase, antibody

gray matter

Guillain Barre syndrome

head injury

headache

hearing loss

hemianopia, homonymous

hemifacial atrophy

hemiparesis

hemiplegia, progressive

herpes simplex encephalitis

herpes simplex encephalitis, diagnosis of

herpes simplex virus

herpes virus infection

herpes zoster

heterochromia iridis

highly active antiretroviral therapy

hippocampal atrophy

hippocampus

hippocampus, hyperintense

Hodgkin's disease

Hodgkin's disease, neurologic involvement with

Horner's syndrome

Horner's syndrome, etiologies of

human immunodeficiency virus type 1

hydrocephalus

hyperreflexia

hypertension

hypertensive encephalopathy

iatrogenic neurologic disorders

immune checkpoint inhibitors

immune reconstitution inflammatory syndrome

immune-related adverse events

immunocompetent

immunologic disease

immunology and the nervous system

immunomodulation

immunosuppression

immunosuppressive agents

intellectual deterioration

interferon

interferon beta 1-a

interferon beta 1-b

intracerebral hemorrhage

Jakob-Creutzfeldt disease

JC virus

Kernig's sign

Klumpke palsy

laminectomy, cervical

laughing, pathologic

leucine rich glioma inactivated 1 antibodies

leukodystrophy

leukoencephalopathy

leukoencephalopathy, differential diagnosis

levamisole

level of consciousness, decreased

lymphadenopathy, hilar

lymphoma

lymphoma involving CNS

lymphoma, primary of CNS

malformation, vascular, cerebral

malignancy screen

malignancy, occult

Marchiafava-Bignami disease

memory, defect of recent

memory, impairment of

mental status, abnormal

mesial temporal lobe

methotrexate

midbrain, lesion of

middle cerebellar peduncle

middle cerebellar peduncle, lesion

migraine

miosis

misdiagnosis

mitochondrial disease

mitoxantrone

monoclonal antibodies

mononeuritis multiplex

mononeuropathy

mononeuropathy multiplex

motor neuron disease

MRI

MRI, abnormal

MRI, contrast enhanced

MRI, contrast enhanced, delayed

MRI, contrast enhanced, high dose

MRI, demyelinating disease

MRI, diffusion tensor

MRI, diffusion weighted

multiple sclerosis, benign form of

multiple sclerosis, chronic progressive

multiple sclerosis, clinical patterns

multiple sclerosis, cost of

multiple sclerosis, diagnosis of

multiple sclerosis, diagnostic criteria

multiple sclerosis, differential diagnosis of

multiple sclerosis, disability status scale

multiple sclerosis, misdiagnosis

multiple sclerosis, monosymptomatic

multiple sclerosis, prognosis

multiple sclerosis, prophylaxsis

multiple sclerosis, relapsing

multiple sclerosis, secondary progressive

multiple sclerosis, treatment of

multiple sclerosis, treatment of, first attack

multiple sclerosis, tumefactive

mutism

myasthenia gravis, paraneoplastic

myasthenic syndrome

myelopathy

myelopathy, ischemic

myelopathy, necrotizing

neoplasm, metastatic to CNS

neoplasm, primary intracerebral

neoplasm, primary of CNS

neurologic complications of, surgery

neurologic complications of, systemic disease

neurologic disease

neurologic disease, diagnoses of

neurologic disease, multifocal

neurologic examination

neurologic practice

neurologic signs

neuromuscular junction

neuronal cell surface antigen

neuronopathy, sensory

neuropathology

neuropathy

neuropathy, paraneoplastic

neuropathy, peripheral

neuropathy, sensory

NMDA antagonists

ocrelizumab

onconeural antibodies

opportunistic infection

opportunistic infection, CNS

opsoclonus-myoclonus syndrome

otitis, neurologic complications with

palatal myoclonus

pancoast tumor

paraneoplastic cerebellar degeneration

paraparesis

paraparesis, spastic

paraproteinemia

paratrigeminal syndrome

peripheral nerve, lesion of

PLEDs, bilateral independent

PLEDs, etiology of

pleocytosis of cerebrospinal fluid

poliomyelitis

polyneuropathy

posterior inferior cerebellar artery syndrome

posterior leukoencephalopathy syndrome

practice guidelines

precipitating factors

primary lateral sclerosis

prion disease

prognosis

progressive multifocal leucoencephalopathy

progressive neurologic disorder

prosopagnosia

pseudobulbar palsy

psychological testing

psychomotor retardation

pulmonary nodules

pupil

pupil, abnormality in neurologic disorders

pyramidal tract

pyramidal tract dysfunction

quadriparesis

quadriplegia

quality of life

radiation therapy, CNS treatment and complications with

radiculitis

rapidly progressing neurologic illness

ReBUILD study

Red flags

rehabilitation for neurologic disorders

release phenomena

remote effect of cancer on the nervous system

saccadic eye movements, abnormal

shunt procedure, ventricular

shunt procedure, ventricular-complications of

sinusitis

Sjogren's syndrome

Sjogren's syndrome, neurologic manifestations of

spasticity

speech disorder

speech, loss of

spinal cord, compression of

spondylosis

steroid

steroid therapy, CNS treatment and complications with

subacute sclerosing panencephalitis(S.S.P.E.)Dawson's disease

symmetric brain lesions

syphilis, diagnosis and treatment

syphilis, neurologic complications with

syringomyelia

systemic lupus erythematosus

tau protein

temporal lobe

temporal lobe, lesion

temporal lobe, lesion, bilateral

Thies's sign

thrombocytopenia

thyroiditis

tongue, impaired movements of

tonsillectomy

toxic encephalopathy

toxoplasmosis, acquired

toxoplasmosis, CNS

transient neurologic deficit

treatment of neurologic disorder

trigeminal neuropathy

trigeminal neuropathy, sensory

tuberculosis

tumefactive lesion

tumor necrosis factor

tumor necrosis factor inhibitor

vaccination, neurologic complications with

vaccine

vasculitides

vasculopathy

vertebral-basilar insufficiency

viral infection

viral infection, CNS

viral infection, reactivation

visual evoked response

visual loss

Waldenstrom's macroglobulinemia

walking, difficulty with

white matter, dirty-appearing

workup

xerophthalmia

xerostomia

Showing articles 700 to 750 of 9392 << Previous Next >>

Alemtuzumab CARE-MS II 5-year follow-up
Neurol 89:1117-1126, Coles, A.J.,et al, 2017

Long-Term Outcomes of Patent Foramen Ovale Closure or Medical Therapy after Stroke
NEJM 377:1022-1032,1006,1093, Saver, J.L.,et al, 2017

Patent Foramen Ovale Closure or Anticoagulation Vs. Antiplatelets after Stroke
NEJM 377:1011-1021,1006,1093, Mas, J.L,et al, 2017

Five Cases of Malignant Melanoma During Fingolimod Treatment in Dutch Patients with MS
Neurol 89:970-972, Killestein, J.,et al, 2017

A 57-year-old man with Unilateral Anosmia, Papilledema, and Meningismus
Neurol 89:e86-e90, Bradshaw, M.J.,et al, 2017

Clinicopathologic Conference, Diffuse Large B-Cell Lymphoma Consistent with Neurolymphomatosis
NEJM 376:2471-2481, Case 19-2017, 2017

A 58-year-old man with Progressive Ptosis and Walking Difficulty
Neurol 89:e1-e5, Kuo, P.,et al, 2017

Clinicopathologic Conference, Advanced AIDS Complicated by HSV-1 Encephalopathy. Basal-Cell Carcinoma. Kaposis Sarcoma.
NEJM 376:2580-2589, Case 20-2017, 2017

A 54-year-old woman with Dementia, Myoclonus, and Ataxia
Neurol 89:e7-e12, Ali, F.,et al, 2017

A Man with Rapidly Ascending Paralysis
Neurol 89:e25-e31, Rosenberg, J.,et al, 2017

Clinicopathologic Conference, Primary Progressive Aphasia, Semantic Variant, due to TAR DNA Binding Protein 43 associated Frontotemporal Lobar Degen
NEJM 376:158-167, Case 1-2017, 2017

Ocrelizumab versus Interferon Beta-1a in Relapsing Multiple Sclerosis
NEJM 376:221-234,280, Hauser, S.L.,et al, 2017

Clinicopathologic Conference, Granulomatous Amebic Encephalitis and Sarcoidosis (Inactive)
NEJM 376:368-379, Case 3-2017, 2017

Pregnancy, Hormonal Treatments for Infertility, Contraception, and Menopause in Women After Ischemic Stroke
Stroke 48:501-506, Caso, V.,et al, 2017

Transient Smartphone Blindness: Relevance to Misdiagnosis in Neurologic Practice
Neurol 88:809-810, Sathiamoorthi, S. & Wingerchuk, D.M.,et al, 2017

Personality Changes, Executive Dysfunction, and Motor and Memory Impairment
JAMA Neurol 74:245-246, Lopez Chiriboga, A.S.,et al, 2017

Cerebellar Ataxia and Hearing Impairment
JAMA Neurol 74:243-244, Lin, C.Y. & Kuo, S.H., 2017

Gradually Progressive Spastic Ataxia in a Young Man Steadily Unsteady
JAMA Neurol 74:238-241, Dubey, D.,et al, 2017

Monitoring long-term Efficacy of Fampridine in Gait-Impaired Patients with Multiple Sclerosis
Neurol 88:832-841, Filli, L.,et al, 2017

Neurofilament as a Blood Marker for Diagnosis and Monitoring of Primary Progressive Aphasias
Neurol 88:961-969, Steinacker, P.,et al, 2017

Intracranial Dural Arteriovenous Fistulae
Stroke 48:1424-1431, Reynolds, M.R.,et al, 2017

A 13-year-old boy with Chronic Ataxia and Developmental Delay
Neurol 88:e116-e121, Libdeh, A.A.,et al, 2017

Diagnosis of Multiple Sclerosis: Progress and Challenges
Lancet 389:1336-1346, Brownlee, W.J.,et al, 2017

A Woman in her 40s with Headache and New-Onset Seizures
JAMA Neurol 74:476-480, Graham, M.S.,et al, 2017

High Hypothetical Interest in Physician-Assisted Death in Multiple Sclerosis
Neurol 88:1528-1534, Marrie, R.A.,et al, 2017

Clinicopathologic Conference, MELAS (mitochondrial encephalopathy, lactic acidosis, and stroke like episodes)
NEJM 376:1668-1678, CASE 13-2017, 2017

Action Tremor, Impaired Balance, and Executive Dysfunction in Midlife
JAMA Neurol 74:603-604, Birch, R.C. & Trollor, J.N., 2017

A Middle-aged man with Progressive Ophthalmoparesis, Ataxia, and Spastic Paraparesis
JAMA Neurol 74:733-736, Kung, N.H.,et al, 2017

Intractable Epilepsy and Progressive Cognitive Decline in a Young Man
JAMA Neurol 74:737-740, Cohen, A.L.,et al, 2017

Advances in Progressive Supranuclear Palsy: New Diagnostic Criteria, Biomarkers, and Therapeutic Approaches
Lancet Neurol 16:552-563, Boxer, A.L.,et al, 2017

Late Onset Neuromyelitis Optica Mimicking an Acute Stroke in an Elderly Patient
J Neuroimmunol 309:1-3, Suchdev, K.,et al, 2017

Huntington Disease: Clinical Features and Diagnosis
UptoDate Dec 2017, Oksana Suchowersky, 2017

Clinical Presentation and Prognosis in MOG-antibody Disease: A UK Study
BRAIN 140:3128-3138, Jurynczyk, M.,et al, 2017

Spinocerebellar Ataxia Type 2: Clinicogenetic Aspects, Mechanistic Insights, and Management Approaches
Front Neurol doi:10.3389/fneur.2017.00472, Velazquez-Perez, L.C.,et al, 2017

Powassan Virus-A New Reemerging Tick-Borne Disease
Front Public Health 5:342, Fatmi,S.S., et al, 2017

Persistent Hyperthermia in a Patient with Aquaporin-4-Antibody-Positive Neuromyelitis Optica Spectrum Disorder
J Clin Neurol 12:515-516, Hsu,C-L.,et al, 2016

Clinical Interpretation of High-Resolution Vessel Wall MRI of Intracranial Arterial Diseases
Br J Radiol 89:20160496, Lehman,V.T.,et al, 2016

SPG7 Mutations Explain a Significant Proportion of French Canadian Spastic Ataxia Cases
Eur J Hum Genet 24:1016-1021, Choquet,K.,et al, 2016

Magnetic Resonance Imaging of Cerebral Aspergillosis: Imaging and Pathological Correlations
PLoS ONE 11:DOI:10.1371/Journal.pone.0152474, Marzoif, G.,et al, 2016

Mechanisms, Causes, and Effects of Hypercapnia
UptoDate Dec, Feller-Kopman, D.J. & Schwartzstein, R.M., 2016

A Woman with Intellectual Disability, Amenorrhoea, Seizures, and Balance Problems
JAMA Neurol 73:1494-1495, Hughes, A.J.C.,et al, 2016

Long-Term Treatment of Epilepsy with Everolimus in Tuberous Sclerosis
Neurol 87:2408-2415, Krueger, D.A.,et al, 2016

Acute Cholecystitis During Treatment with Alemtuzumab in 3 Patients with RRMS
Neurol 87:2380-2381, Pfeuffer, S.,et al, 2016

A 34-Year-Old Man with Headache, Diploplia, and Hemiparesis
Neurol 86:e28, Lincoln, M.R.,et al, 2016

Validation of Clinicoradiological Criteria for the Diagnosis of Cerebral Amyloid Angiopathy-Related Inflammation
JAMA Neurol 73:197-202, Auriel, E.,et al, 2016

A 37-Year-Old Man with Multiple Cranial Neuropathies
Neurol 86:e66-e70, OLoghlen, S.,et al, 2016

Silent Brain Infarction and Risk of Future Stroke
Stroke 47:719-725, Gupta, A.,et al, 2016

Neuromyelitis Optica: Evaluation of 871 Attacks and 1,153 Treatment Courses
Ann Neurol 79:206-216,204, Kleiter, I.,et al, 2016

A 71-year-old Man with Rapidly Progressive Dementia
Neurol 86:e89-e92, Niemann, N.,et al, 2016

Discriminating Long Myelitis of Neuromyelitis Optica from Sarcoidosis
Ann Neurol 79:437-447, Flanagan, E.P.,et al, 2016

Showing articles 700 to 750 of 9392 << Previous Next >>